You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

vulvar cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Skin Necrosis, Complication Trial in A Coruña (ICG angiography)

Recruiting
  • Skin Necrosis
  • Complication
  • ICG angiography
  • A Coruña, Spain
    Hospital Abente y Lago
Jun 17, 2023

Cancer Metastatic to Liver, Cancer Colorectal Trial in Copenhagen (Exercise)

Not yet recruiting
  • Cancer Metastatic to Liver
  • Cancer Colorectal
  • Exercise
  • Copenhagen, Denmark
    Rigshospitalet (CFAS)
Oct 11, 2022

NSCLC Stage IV, EGFR Gene Mutation Trial in Worldwide (Osimertinib, Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • NSCLC Stage IV
  • EGFR Gene Mutation
  • Alessandria, Italy
  • +15 more
Mar 29, 2022

Cancer, Cancer of Lung Trial in Herlev (Exercise intervention, Standard oncological treatments)

Recruiting
  • Cancer
  • Cancer of Lung
  • Exercise intervention
  • Standard oncological treatments
  • Herlev, Denmark
    Herlev Hospital
Mar 16, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV NSCLC AJCC v7 Trial in Denver, Houston, London (other, radiation, procedure)

Active, not recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Clinical Observation
  • +5 more
  • Denver, Colorado
  • +2 more
Feb 10, 2022

Colorectal Cancer, Adenoma Colon, Polyp of Colon Trial in Bad Salzuflen, Milan, Portsmouth (Computer Aided Detection (CADe))

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Computer Aided Detection (CADe)
  • Bad Salzuflen, Germany
  • +2 more
Dec 23, 2022

Cancer, Adjustment Disorders Trial in Rockville (MDMA)

Recruiting
  • Cancer
  • Adjustment Disorders
  • Rockville, Maryland
    Sunstone Medical, PC
Oct 13, 2022

Bladder Cancer Trial in United States (Nivolumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • Duarte, California
  • +6 more
Jul 7, 2022

Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced

Active, not recruiting
  • Breast Cancer
    • Copenhagen, Denmark
      Danish Breast Cancer Group
    Jul 6, 2022

    Endometrial Cancer Trial in Little Rock (Fluorescein)

    Completed
    Has Results
    • Endometrial Cancer
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Feb 10, 2022

    Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

    Recruiting
    • Advanced Urothelial Carcinoma
    • +3 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jun 28, 2022

    Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

    Active, not recruiting
    • Breast Neoplasms
    • +7 more
    • Goodyear, Arizona
    • +38 more
    Jun 29, 2022

    Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • London, United Kingdom
      Barts Health NHS Trust
    Aug 10, 2022

    Cancer Related Pain Trial (NanaBis™, Oxycodone CR, Placebo Spray)

    Not yet recruiting
    • Cancer Related Pain
    • (no location specified)
    Apr 4, 2022

    Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3 Trial in Washington, Hackensack (NY-ESO-1 Peptide

    Not yet recruiting
    • Ovarian Cancer Stage IV
    • +2 more
    • Washington, District of Columbia
    • +2 more
    Jul 28, 2022

    Prostate Cancer Trial in London (Imaging Panel)

    Active, not recruiting
    • Prostate Cancer
    • Imaging Panel
    • London, Ontario, Canada
      London Health Sciences Centre
    Dec 14, 2021

    Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

    Recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 8, 2022

    Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

    Not yet recruiting
    • Recurrent Biliary Tract Carcinoma
    • +13 more
    • (no location specified)
    Nov 8, 2022

    Breast Cancer, Radiotherapy Side Effect Trial in Graz (Simultaneous integrated boost)

    Withdrawn
    • Breast Cancer
    • Radiotherapy Side Effect
    • Simultaneous integrated boost
    • Graz, Austria
      Medical University of Graz
    Oct 7, 2022

    Fatigue, Breast Cancer Trial in Switzerland (Eurythmy therapy, CoordiFit)

    Recruiting
    • Fatigue
    • Breast Cancer
    • Eurythmy therapy
    • CoordiFit
    • Basel, Switzerland
    • +10 more
    Feb 17, 2022

    Blood and Tissue Samples From Locally Recurrent or Metastatic

    Recruiting
    • Localized Renal Pelvis and Ureter Urothelial Carcinoma
    • +10 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 21, 2021

    Radiodermatitis, Breast Tumors, Side Effect Trial (Mepitel Film)

    Completed
    • Radiodermatitis
    • +2 more
    • Mepitel Film
    • (no location specified)
    Nov 14, 2023

    Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

    Recruiting
    • Microsatellite Stable Metastatic Colorectal Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 19, 2023

    Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

    Recruiting
    • Acute Lymphoid Leukemia
    • +3 more
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Jul 24, 2023

    ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

    Recruiting
    • Breast Cancer Female
    • +4 more
      • Ho Chi Minh City, Vietnam
      • +1 more
      Oct 16, 2023